Xcellerex forms biomanufacturing deal with Gallus

Xcellerex Inc., a Marlborough provider of manufacturing systems for biotherapeutics and vaccines, has formed a collaboration deal with St. Louis-based Gallus BioPharmaceuticals LLC.

The collaboration is expected to help Gallus round out its biologics contract manufacturing organization with more manufacturing and laboratory capabilities. The deal calls for Gallus to acquire Xcellerex’s small scale 10L bioreactors, along with its FlexFactory cGMP manufacturing that uses XDR single-use bioreactors for up to 2,000 liters.